Coya Therapeutics (COYA) Revenue & Revenue Breakdown
Coya Therapeutics Revenue Highlights
Latest Revenue (Y)
$3.55B
Coya Therapeutics Revenue by Period
Coya Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $3.55B | 59112.58% |
2023-12-31 | $6.00M | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | - |
Coya Therapeutics generated $3.55B in revenue during NA 2024, up 59112.58% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Coya Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | -100.00% |
2024-06-30 | $3.43M | 2600.51% |
2024-03-31 | $126.84K | -97.89% |
2023-12-31 | $6.00M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | - |
Coya Therapeutics generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Coya Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
COYA | Coya Therapeutics | $3.55B | - |
DAWN | Day One Biopharmaceuticals | $131.16M | $20.07M |
STRO | Sutro Biopharma | $62.04M | $25.71M |
FENC | Fennec Pharmaceuticals | $47.54M | $6.97M |
CUE | Cue Biopharma | $5.49M | $3.34M |
TCRX | TScan Therapeutics | $2.82M | - |
OPT | Opthea | $108.41K | $61.27K |
LTRN | Lantern Pharma | - | - |
CGTX | Cognition Therapeutics | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
CNTA | Centessa Pharmaceuticals | - | - |
INAB | IN8bio | - | - |
HLVX | HilleVax | - | - |
TERN | Terns Pharmaceuticals | - | - |
DRMA | Dermata Therapeutics | - | - |
GANX | Gain Therapeutics | - | - |